This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight Reset

This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight Reset

Key PointsDAFNA Capital Management sold 222,847 SNDX shares in the fourth quarter for an estimated roughly $4 million.Meanwhile, the quarter-end position value decreased by $1.87 million, reflecting both trading and price movements.The position now represents roughly 1.4% of reportable AUM, outside the fund’s top five holdings.10 stocks we like better than Syndax Pharmaceuticals › DAFNA Capital Management reported selling 222,847 shares of Synda…